How many mg is 80 units of tirzepatide depends on your vial's concentration. At the most common 10 mg/ml concentration, 80 units of tirzepatide equals 8 mg. If your vial is 5 mg/ml, 80 units equals 4 mg. At 20 mg/ml, 80 units equals 16 mg, which slightly exceeds the FDA-approved maximum of 15 mg per week. Always verify your specific vial's concentration label before drawing this higher-volume dose. Use our GLP-1 dose calculator.

Quick Answer Table: 80 Units of Tirzepatide to mg

The same 80 units measurement on your syringe delivers different mg amounts depending on the vial concentration.

Concentration

Volume (80 units)

mg of Tirzepatide

5 mg/ml

0.8 ml

4 mg

10 mg/ml (most common)

0.8 ml

8 mg

20 mg/ml

0.8 ml

16 mg (above FDA max)

Here is what to know up front about 80 units of tirzepatide mg conversion. The 80 unit mark on a U100 insulin syringe always represents 0.8 ml of volume. The mg amount in that 0.8 ml depends on the vial concentration. At the most common 10 mg/ml concentration, tirzepatide 80 units delivers 8 mg, which is an in-between dose between the standard 7.5 mg and 10 mg titration steps. The math follows FDA prescribing information. For broader conversion context, see how many mg in a ml.

The Math: How We Calculated This

The formula for 80 units to mg tirzepatide conversion is:

mg = (units ÷ 100) × concentration (mg/ml)

Worked example at 10 mg/ml (most common):

80 units ÷ 100 = 0.8 ml 0.8 ml × 10 mg/ml = 8 mg

At 5 mg/ml: 80 ÷ 100 = 0.8 ml 0.8 ml × 5 mg/ml = 4 mg

At 20 mg/ml: 80 ÷ 100 = 0.8 ml 0.8 ml × 20 mg/ml = 16 mg (above FDA-approved maximum of 15 mg)

The 0.8 ml volume stays the same. The mg dose changes because each concentration delivers a different amount of tirzepatide per ml.

Why Concentration Determines the mg Dose

How much is 80 units of tirzepatide depends on the vial concentration. The same 80 units can be 4 mg, 8 mg, or 16 mg depending on which compounding pharmacy made your vial.

This matters most at higher volumes. At 20 mg/ml, 80 units delivers 16 mg, which exceeds the FDA-approved maximum tirzepatide dose of 15 mg per week. If you intended a 15 mg max dose and drew 80 units from a 20 mg/ml vial, you would receive slightly more than the FDA-approved limit.

For 80 units tirzepatide, always verify the concentration before each draw. The math at higher doses leaves less room for error.

What Does an 8 mg Tirzepatide Dose Mean?

If you are using a 10 mg/ml vial and drawing tirzepatide 80 units, you are receiving 8 mg of tirzepatide. This is an in-between dose, not a standard FDA-approved titration step.

The FDA-approved standard doses are 2.5, 5, 7.5, 10, 12.5, and 15 mg. An 8 mg dose falls between the standard 7.5 mg and 10 mg steps. This dose might appear if:

  • Your physician prescribed a custom titration plan

  • You intended 75 units (7.5 mg) or 100 units (10 mg) but miscounted

  • A slow titration protocol uses non-standard intermediate doses

If you intended a standard dose (75 units for 7.5 mg, or 100 units for 10 mg), drawing 80 units gives a non-standard amount. Confirm your prescribed unit count before injecting.

Common Concentrations and 80 Units

For full conversion charts, see the compounded tirzepatide dosage guide.

At 5 mg/ml concentration: 80 units = 4 mg tirzepatide. This is between the standard 2.5 mg and 5 mg titration steps. Uncommon in standard protocols.

At 10 mg/ml concentration (most common): 80 units = 8 mg tirzepatide. This is between the standard 7.5 mg and 10 mg titration steps. A non-standard in-between dose.

At 20 mg/ml concentration: 80 units = 16 mg tirzepatide. This exceeds the FDA-approved maximum of 15 mg per week. Doses above 15 mg are not FDA-approved and have limited long-term safety data.

Safety Note for 80 Units at 20 mg/ml

At 20 mg/ml, drawing 80 units delivers 16 mg of tirzepatide, which is 1 mg above the FDA-approved maximum dose. While the 1 mg margin may seem small, the FDA set 15 mg as the maximum because higher doses were not adequately tested in Phase 3 clinical trials.

If you have a 20 mg/ml vial and your prescribed dose is 15 mg, you should draw 75 units (not 80). The 5 unit difference at 20 mg/ml represents 1 mg, which keeps your dose at the approved maximum. Always confirm your unit count against your prescribed mg dose, especially with higher-concentration vials.

Frequently Asked Questions

At 10 mg/ml, the most common compounded concentration, 80 units of tirzepatide equals 8 mg. This is an in-between dose, not a standard FDA titration step. Standard FDA doses are 2.5, 5, 7.5, 10, 12.5, and 15 mg.

At 5 mg/ml concentration, 80 units of tirzepatide equals 4 mg. This is between the standard 2.5 mg and 5 mg titration steps. Uncommon in standard protocols.

At 20 mg/ml, 80 units of tirzepatide equals 16 mg, which slightly exceeds the FDA-approved maximum of 15 mg per week. Drawing this dose requires direct physician supervision due to limited long-term safety data above the approved maximum.

No. FDA-approved tirzepatide doses are 2.5, 5, 7.5, 10, 12.5, and 15 mg. An 8 mg dose is an in-between amount that may appear in custom physician protocols but is not a standard titration step.

Units measure volume on the syringe. The mg amount depends on what is dissolved in that volume. Different vial concentrations contain different amounts of tirzepatide per ml, so 80 units (0.8 ml) of a 10 mg/ml vial contains 8 mg, while 80 units of a 20 mg/ml vial contains 16 mg.

Only if your physician specifically prescribed 80 units. The standard 7.5 mg dose is 75 units at 10 mg/ml. Drawing 80 units gives a non-standard 8 mg dose. The 5 unit difference at 10 mg/ml represents 0.5 mg, which is meaningful for therapy consistency.